Tim Guilliams | CEO
Healx Limited

Tim Guilliams, CEO, Healx Limited

Tim is a social entrepreneur passionate about delivering the next generation of therapeutics to rare disease patients in need. He is the Founder and Chief Executive of Healx and the Co-Founder and Chair of the Cambridge Rare Disease Network (CRDN), a charity aiming to foster dialogue and awareness around rare diseases in Cambridge, UK.
Prior to Healx and CRDN, Tim worked on University-Industry interactions in the area of Life Sciences for the UK Government Department for Business, Innovation and Skills (BIS). He obtained his PhD in the field of Biophysical Neuroscience at the University of Cambridge. He is also a Junior Associate Fellow of the Centre for Science and Policy (CSaP). Before moving to Cambridge, he obtained an MEng in Bio-Engineering from the University of Brussels (VUB).


Ai in Healthcare 2018 Day Two @ 17:20

Panel discussion: How can AI and pharma integrate to work together?

  • AI companies can access public data, however struggle to access privately held by pharma companies.
  • Will AI companies and pharma ever be able to work together to share this data?
  • How can we unlock the potential of AI in big pharma?
  • How AI companies can help pharma, and vice versa

back to speakers